Evans John M.'s Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Apr 3, 2024
- Accession no.
- 0000950170-24-041432
- Filed
- Apr 3, 2024
- Trade date
- Apr 1-3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market sales total $581.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Evans John M.CIK 0001786304 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Common Stock | SSaleDisposed | −18,102 | $32.13 | −$581,617.26 | 1,058,343 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2024 | Common Stock | AGrant or awardAcquired | +99,336 | $0.00 | $0 | 99,336 | Direct | |
| Apr 3, 2024 | Common Stock | AGrant or awardAcquired | +53,965 | $0.00 | $0 | 53,965 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.